Eton Pharmaceuticals (ETON) Research & Development (2018 - 2025)

Eton Pharmaceuticals has disclosed Research & Development across 8 years of filings, most recently posting $1.8 million for Q4 2025.

• Research & Development for Q4 2025 came in at $1.8 million, up 304.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.8 million (up 138.56% YoY), and the FY2025 annual result was $7.8 million, up 138.56% from the prior year.
• Research & Development came in at $1.8 million for Q4 2025 at Eton Pharmaceuticals, up from $1.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $3.7 million in Q2 2025 to a low of -$871000.0 in Q4 2024.
• The 5-year median for Research & Development is $915000.0 (2021), against an average of $1.2 million.
• Across the five-year window, Research & Development tumbled 183.19% in 2024 and jumped 304.36% in 2025, its largest moves.
• Eton Pharmaceuticals' Research & Development stood at $681000.0 in 2021, then surged by 38.62% to $944000.0 in 2022, then increased by 10.91% to $1.0 million in 2023, then sank by 183.19% to -$871000.0 in 2024, then surged by 304.36% to $1.8 million in 2025.
• The last three Research & Development figures came in at $1.8 million (Q4 2025), $1.1 million (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.